Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Human Microbiome Market Size Worth $2.92Bn by 2028 at 22.2% CAGR Led by Probiotics Products (24.71% Market Share in 2021) Global Analysis by The Insight Partners

Published

on

 

The Insight Partners published latest research study on “Human Microbiome Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product (Probiotics, Foods, Prebiotics, Medical Foods, Diagnostic Device, Drugs and Supplements), Disease (Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders, and Others) and Application (Therapeutics and Diagnostics) and Geography”, the global human microbiome market size is expected to reach $2.92 billion by 2028 from $0.71 billion in 2021; it is estimated to grow at a CAGR of 22.2% during 2021–2028.

Download PDF Brochure of Human Microbiome Market Size – COVID-19 Impact and Global Analysis with Strategic Developments at: https://www.theinsightpartners.com/sample/TIPBT00002233/

Human Microbiome Market Report Scope & Strategic Insights:

Report Coverage

Details

Market Size Value in

US$ 0.71 Billion in 2021

Market Size Value by

US$ 2.92 Billion by 2028

Growth rate

CAGR of 22.2% from 2021-2028

Forecast Period

2021-2028

Base Year

2021

No. of Pages

188

No. Tables

84

No. of Charts & Figures

78

Historical data available

Yes

Segments covered

Product, Disease and Application and Geography

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Human Microbiome Market: Competitive Landscape and Key Developments

Market leaders operating in the market have undertaken various organic growth strategies in the human microbiome market. The human microbiome market majorly consists of the players such as MaaT Pharma, ELIGO BIOSCIENCE, AOBiome, Kaleido Biosciences, Inc., Seres Therapeutics, Merck & Co., Inc, Yakult Honsha Co., Ltd, Rebiotix, Inc., DuPont de Nemours, Inc, and Synthetic Biologics, Inc. amongst others. Some of the activities undertaken by the company, which have promoted its growth are, product launch, approvals, partnership and strategy and business planning. Companies such MaaT Pharma, AOBiome, Seres Therapeutics, Inc and others have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market.

Inquiry Before Purchase: https://www.theinsightpartners.com/inquiry/TIPBT00002233/

In June-21, MaaT Pharma received Data Safety and Monitoring Board (DSMB) approval to proceed to cohort study on phase 1b trial for testing capsule formulation of microbiome ecosystem therapy.

In June-21, Yakult Honsha Co., Ltd. has expanded its facility by construction of new plant in Mindanao, Philippines. The production capacity is planned to be 1.6 million bottles per day at the start of operations. The facilities will be expanded subsequently, and the Company expects the maximum production capacity to reach 3.2 million bottles per day.

In June-21, Seres Therapeutics, Inc. has received U.S. Food and Drug Administration (FDA) clearance for SER-155 under an Investigational New Drug (IND) application. SER-155 is an investigational oral, rationally-designed, cultivated microbiome therapeutic designed to reduce the incidence of gastrointestinal antibiotic-resistant bacterial infections, bacteremia and graft-versus-host disease (GvHD) in immunocompromised patients.

In January-21, Eligo Bioscience has entered research partnership with GlaxoSmithKline. This partnership is aimed at advancing Eligo biotics for the treatment or prevention of acne vulgaris with a pioneering CRISPR-based therapeutic for strain-specific microbiome modulation.

Have a question? Speak to Research Analysthttps://www.theinsightpartners.com/speak-to-analyst/TIPBT00002233

In January-20, Kaleido Biosciences, Inc. collaborated with Janssen’s World Without Disease Accelerator, part of the Janssen Pharmaceutical Companies of Johnson & Johnson. The collaboration is likely to explore the potential for Kaleido’s Microbiome Metabolic Therapies (MMT) for the prevention of the onset of childhood allergy and other atopic, immune, and metabolic conditions by driving specific microbiome features which support an appropriate maturation of the infant immune system.

The Human Microbiome Market growth is mainly attributed to factors such as the increasing incidence of lifestyle diseases, rising focus on human microbiome therapies, and growing technological advancements in metagenomics and next-generation sequencing. However, strict government guidelines and lack of knowledge about detailed examination hinder the Human Microbiome Market growth.

Humans coexist with the diverse microbial species inhabiting within and on the surface of their bodies. Recent studies have highlighted that these microbial communities are essentially serving as another organ of the body as they play crucial roles in human physiology and disease progression. Several basic and translational research efforts have been initiated to focus on deciphering the microbiome function and its benefits to the human health. Many human medical conditions, such as inflammatory bowel diseases and obesity, have been closely associated with the composition of the gut microbial community; furthermore, conditions such as asthma and diabetes are thought to be influenced this microbial community. Many efforts are being taken to alter the gut microbiome to eradicate several diseases. Probiotics, prebiotics dietary supplements, and foods that contain live microbes have been studied thoroughly to assess their effects on human health. Also, several companies are designing and developing various microbiome therapies. Rebiotix Inc. has developed Microbiota Restoration Therapy (MRT) drug platform for delivering healthy, live, human-derived microbes into a sick patient’s intestinal tract to treat disease. Thus, the increasing focus on human microbiome therapies is the prime factor driving the growth of human microbiome market in the coming years.

Avail Lucrative DISCOUNTS on “Human Microbiome Market” Research Studyhttps://www.theinsightpartners.com/discount/TIPBT00002233/

Based on product, the human microbiome market is further segmented into probiotics, foods, prebiotics, medical foods, diagnostic device, drugs and supplements. The human microbiome market on the basis of products is segmented into probiotics, foods, prebiotics, medical foods, diagnostic devices, drugs, and supplements. The probiotics segment is expected to hold the largest market share of 24.71% in 2021. This segment is also expected to dominate the market in 2028, and increasing concerns regarding health; growing awareness about the relation between nutrition, diet, and health; and surging penetration of probiotics in dairy and other food & beverages industries would favor the overall demand in the coming years. Furthermore, the prebiotics segment is anticipated to register the highest CAGR in the human microbiome market during 2021–2028.

The human microbiome market, by disease, is segmented into diabetes, cancer, autoimmune disorders, obesity, mental disorders, and other diseases. Based on application, the market is segmented into diagnostics and therapeutics.

The World Health Organization (WHO), National Health Service (NHS), Centers for Disease Control and Prevention (CDC), Centers for Medicare and Medicaid Services, American Academy of Dermatology, and company websites are among the major primary and secondary sources referred to while preparing the report on the human microbiome market.

Technological advancements in metagenomics and next-generation sequencing have made microbiome-based testing easier and cheaper, and they have sped up the process of analysis of the genomic content of microorganisms from human sample. This has bolstered the development process for microbiome-based diagnostics. Gastrointestinal and metabolic disorders accounted for a large share of the diagnostics market in 2018 owing to high interest in developing an easy analysis platform for gut health-based disorders, such as irritable bowel syndrome and Crohn’s disease. Metabiomics is engaged in developing molecular diagnostics for detecting markers of colorectal cancer. Existing tests for colorectal cancer rely on invasive colonoscopies; and thus, the non-invasive test developed by Metabiomics that uses stool samples to evaluate patient’s gut microbiome would come up as a unique product meeting huge unmet need.

Directly Purchase Premium Copy of Human Microbiome Market Growth Report (2021-2028) at: https://www.theinsightpartners.com/buy/TIPBT00002233/

On the basis of geography, the human microbiome market is segmented into North AmericaEuropeAsia Pacific (APAC), the Middle East & Africa (MEA), and South & Central America (SCAM). North America is projected to hold the largest market share in 2021, with the US being the leading shareholder, followed by Canada. The market growth in North America is credited to robust research activities in the human microbiome, increasing funding for biotechnology, rising health-consciousness among population, and surge in the demand for the probiotics and prebiotic to treat chronic diseases. Asia Pacific is expected register the highest CAGR in the human microbiome market during the forecast period. Countries such as China have an established market for human microbiome, whereas the demand in India and Japan is set to grow in the coming years owing the ongoing research and developments.

Browse Adjoining Reports:

Human Microbiome Sequencing Technology Market Forecast to 2028 – COVID-19 Impact and Global Analysis by Type (Traditional Sequencing Technologies, Next-Generation Sequencing, Third Generation Sequencing); End User (Research and Academic Institutions, Pharmaceutical and Biotechnology Companies, Others) and Geography

Human Microbiome Sequencing Market Forecast to 2028 – COVID-19 Impact and Global Analysis by Product Type (Assay Kits, Instruments, Software); Technology (Next-Generation Sequencing, Traditional Sequencing Technologies, Other Sequencing Technologies); Application (Disease Diagnosis, Drug Discovery, Consumer Wellness, Omics Analysis, Other Applications); End Users (Research and Academic Institutions, Pharmaceutical and Biotechnology Companies, Other End Users)

Human Microbiome Based Drugs and Diagnostics Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product (Food, Probiotics, Prebiotics, Medical Food, Diagnostic Devices, Drugs, Other Probiotic Supplements); Application (Therapeutics, Diagnnostics); Disease (Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders, Other Diseases); Research Spending, product Type (Instruments, Consumables); Research spending, Technology Type (Cell Culture Technology, High Throughput Technology, Omics Technology) and Geography

Human Microbiome Sequencing Instrument Market Forecast to 2028 – COVID-19 Impact and Global Analysis by Type (Reagents and Kits, Instruments, Liquid Handling Instruments, Cytometers, Imaging Devices, Microplate Reader, Others); Applications (Research and Academic Institutions, Pharmaceutical and Biotechnology Companies, Hospital and Clinic, Others) and Geography

Metagenomics Market to 2027 – Global Analysis and Forecasts by Product (Instruments & Software and Consumables), Application (Clinical Diagnostics, Drug Discovery Metagenomics and Others) and Geography

Metagenomics Sequencing Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product and Service (Instruments, Reagents and Consumables, Software and Service); Technology (Shotgun Metagenomic Sequencing, RNA Sequencing, Whole-Genome Sequencing and De Novo Assembly, Metatranscriptomics); Application (Drug Discovery, Clinical Diagnostics, Others), and Geography

Microbiome Drugs Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Type (Probiotics, Prebiotics, Small Molecules, Biological Drugs, Others.); Application (Autoimmune Diseases, Inflammatory Bowel Diseases, Cancer, Others.); End-Users (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.) and Geography

Microbiome Sequencing Services Market Forecast to 2028 – Covid-19 Impact and Global Analysis – by Technology (Sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, Other technologies); Application (Diagnostics, Drug discovery, Others) and Geography

Microbiome Therapeutics Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Indication (Type 2 diabetes, Obesity, C. Difficile Infection, Primary Hyperoxyurea, Crohn’s Disease, Inflammatory Bowel Diseases, Ulcerative Colitis); End User (Hospital, Clinics, Ambulatory Surgery Center, Others) and Geography

Artificial Intelligence

INSPIRED BY A FIFTIES AUTOMOTIVE LEGEND: INTRODUCING AUTOMOBILI PININFARINA BATTISTA CINQUANTACINQUE

Published

on

inspired-by-a-fifties-automotive-legend:-introducing-automobili-pininfarina-battista-cinquantacinque

Battista Cinquantacinque bears the iconic Blu Savoia Gloss bodywork and contrasting Bianco Sestriere Gloss roof which is inspired by the original 1955 Lancia Florida show carCinquantacinque name, derived from the Italian word for 55, pays tribute to the iconic Pininfarina-designed classic carElegant Lancia Florida was a favourite of the man who penned the classic model and who gave his name to the fastest and most powerful Italian road car – Battista ‘Pinin’ FarinaOne-of-a-kind Battista Cinquantacinque pictured alongside one of only three Lancia Florida sedansAutomobili Pininfarina Design Team was inspired by the 1955 Lancia Florida when also creating the PURA Vision design concept, which sets the template for all future Automobili Pininfarina modelsAccompanying assets available to download hereCAMBIANO, Italy, May 8, 2024 /PRNewswire/ — Automobili Pininfarina has curated a unique Battista commission as a fitting tribute to the 1955 Lancia Florida – a vehicle designed and loved by Battista ‘Pinin’ Farina.

 
 
The Lancia Florida was penned by Battista ‘Pinin’ Farina in the early fifties. It was renowned as a rolling sculpture which inspired new design perspectives. Pinin’s personal Florida, which can be admired as part of the Pininfarina SpA Collection in Cambiano (Torino), was the daily driver of Carrozzeria Pininfarina’s founder throughout his career. The stunning Battista Cinquantacinque hyper GT pays homage to this unique heritage.
Its exterior is finished in a flawless Blu Savoia Gloss paint, contrasted by the Bianco Sestriere Gloss roof and completed by the elegant Brushed Anodised jewellery pack. Inside, it is upholstered in a bespoke Mahagoni (Poltrona Frau Heritage Leather). The livery and name Cinquantacinque, translating to ’55’ in Italian, elegantly honours the iconic, classic 1955 Lancia Florida, styled by Carrozzeria Pininfarina.
The Cinquantacinque model features a number of unique inscriptions that point to its heritage and provenance. The passenger door plate as well as the underside of the active rear wing both feature the ‘Cinquantacinque 55’ signature.
Each Battista is propelled by four independent electric motors and a powerful 120 kWh lithium-ion battery, delivering 1,900hp and 2,340Nm of torque. This advanced powertrain ensures thrilling performances, such as accelerating 0-100 kph in 1.86 seconds and 0-200 kph in 4.75 seconds, as well as a comfortable driving range of up to 476 km.
The Battista Cinquantacinque will make its public debut in Tokyo, Japan, when it is introduced to clients in the region, alongside retail partner, SKY GROUP, as part of Automobili Pininfarina’s continued global expansion.
Clients in the region will get to see Automobili Pininfarina’s promise of ‘Dream Cars. Made Real.’ first-hand, providing a personalised client experience and ensuring every hand-crafted vehicle to leave the Atelier facility in Cambiano destined for Japan is a unique expression of each client’s personality.
Dave Amantea, Chief Design Officer at Automobili Pininfarina, said: “This was a truly special and unique opportunity to design a car that plays homage to Pininfarina SpA’s heritage. The colour combination of the Battista Cinquantacinque is incredible and shows the vision Battista Farina had when he designed the Lancia Florida back in the early fifties. Not only that, but that very same model helped guide me when creating the PURA Vision design concept, a truly unique vehicle that sets the template for future models from Automobili Pininfarina.”
The Lancia Florida sedan not only inspired the Cinquantacinque Battista, but also some of the key design elements of the PURA Vision design concept, a vehicle which sets the template for all future Automobili Pininfarina models.
The 50s sedan has rear-opening doors and no B pillar, which directly translated to the Lounge Doors on the PURA Vision. They hinge dramatically upwards and, in combination with the pillarless opening and rear-hinged back doors, provide unrestricted access to the design concept’s spacious 2+2 seating.
Automobili Pininfarina stands at the vanguard of pure Italian luxury experience, with its bespoke curated approach allowing for precise tailoring to the specific preferences of individual clients. Each vehicle is a unique, hand-crafted masterpiece and a reflection of the client’s personality with inspiration from Automobili Pininfarina’s artisans.
FOR MORE INFORMATION, VISIT: automobili-pininfarina.com/media-hub
EDITOR’S NOTES
ABOUT AUTOMOBILI PININFARINA
Automobili Pininfarina is based in operational headquarters in Cambiano, Italy, with a commercial office in Munich, Germany, and resourced with a team of experienced automotive executives from luxury and premium car brands. Designed, engineered and produced by hand in Italy, with a focus on designing experiences for the world’s foremost taste makers, all of Automobili Pininfarina’s vehicles embody the PURA design philosophy. This philosophy will also permeate all future production cars, seamlessly blending classic inspiration with cutting-edge technology.
THE AUTOMOBILI PININFARINA BATTISTA (LINK TO PRESS KIT)
The Battista is the most powerful car ever designed and built in Italy and it delivers a level of performance that is unachievable today in any road-legal sports car featuring internal combustion engine technology. Faster than a current Formula 1 race car in its 0-100 km/h sub-two second sprint, and with 1,900 hp and 2,340 Nm torque on tap, the Battista will combine extreme engineering and technology in a zero emissions package. The Battista’s 120 kWh battery provides power to four electric motors – one at each wheel – with a combined WLTP range of up to 476 km (U.S. combined EPA: 300 miles) on a single charge. No more than 150 examples of Battista will be individually hand-crafted at the Pininfarina SpA atelier in Cambiano, Italy.
Photo: https://mma.prnewswire.com/media/2406758/Battista_Cinquantacinque_and_1955_Lancia_Florida.jpgPhoto: https://mma.prnewswire.com/media/2406761/Battista_Cinquantacinque_1.jpgPhoto: https://mma.prnewswire.com/media/2406764/Battista_Cinquantacinque_2.jpgPhoto: https://mma.prnewswire.com/media/2406760/Battista_Cinquantacinque_Interior.jpgLogo: https://mma.prnewswire.com/media/1316779/Automobili_Pininfarina_Logo.jpg
 
 
 
 
 

View original content:https://www.prnewswire.co.uk/news-releases/inspired-by-a-fifties-automotive-legend-introducing-automobili-pininfarina-battista-cinquantacinque-302138362.html

Continue Reading

Artificial Intelligence

Exploring the Surge in Digital Infrastructure Spending Driven by Generative AI Innovations

Published

on

exploring-the-surge-in-digital-infrastructure-spending-driven-by-generative-ai-innovations

USA News Group Commentary Issued on behalf of Avant Technologies Inc.
VANCOUVER, BC, May 7, 2024 /PRNewswire/ — USA News Group – The rise of generative AI is currently adding considerable potential for accelerating economic growth across a wide array of sectors. In order to fully realize this potential, analysts at ING are highlighting how crucial investment in data and digital infrastructure will be moving forward. Citing estimates from Dell’Oro and Bank of America, ING has pointed out that investments from big tech companies in digital infrastructure is expected to grow between 15-22% this year alone. Another report from analysts at SNS Insider are projecting the AI Infrastructure Market to hit US$222.42 billion by 2030, growing at an explosive CAGR of 25.5%. Behind the scenes, developments in AI infrastructure are being made and provided by a variety of tech companies that include Avant Technologies Inc. (OTCQB: AVAI), Vertiv Holdings Co (NYSE: VRT), Equinix, Inc. (NASDAQ: EQIX), Innodata Inc. (NASDAQ: INOD), and Salesforce, Inc. (NYSE: CRM).

Earlier this year, Avant Technologies Inc. (OTCQB: AVAI) took a significant step in expanding the capabilities of its flagship AvantAI platform, reinforcing its position as one of the first companies to market generative AI. So far, this enhancement has focused on advancing its high-performance data center infrastructure to accommodate the latest developments in AI technology, including the launch of its state-of-the-art supercomputing network and comprehensive licensable data set. As per the launch, Avant’s platform works in collaboration with tech partners Wired4Health, which the company would later acquire and name its former CFO William Hisey as its new CEO.
“Avant’s supercomputing network and our expansive licensable dataset will facilitate significant advancements in AIdriven solutions,” said Danny Rittman, Chief Information Officer of Avant of the launch. “By providing robust computational resources and a rich dataset, Avant is set to eliminate many of the technical and financial barriers that have traditionally hampered AI development. This initiative aims to empower developers with the tools necessary to create more sophisticated and efficient AI models, driving progress and innovation in innumerable fields.”
Providing even more security for its prospective clients, Avant Technologies has also announced its plans to implement AI-empowered, Zero Trust Architecture (ZTA) across its data center operations. In AI-empowered data centers, Zero Trust Architecture ensures that all users and devices are continuously authenticated and verified before accessing network resources.
“By integrating AI with Zero Trust Architecture, we are creating a robust and future-proof security framework for our data centers,” said William Hisey, Avant’s  newly-appointed CEO. “This combined approach ensures the highest level of security for our customers’ data while optimizing data center operations for efficiency and cost-effectiveness. Avant is committed to providing innovative technology to help businesses optimize data center operations, improve resource utilization, and enhance security.”
Recently, Avant Technologies also expanded its AvantAI™ platform to include smart, proactive monitoring and management for data centers. AvantAI™ boosts data center efficiency through real-time monitoring and proactive management, helping to ensure systems operate continuously and perform optimally. It also uses extensive data analysis to predict and prevent potential issues and dynamically adjusts resources to enhance data traffic efficiency and responsiveness.
Working to further bolster the AI revolution, Vertiv Holdings Co (NYSE: VRT) saw 60% growth in organic orders of its critical digital infrastructure and continuity solutions in Q1 2024 compared to the same time period the year prior, along with 8% higher net sales.
As well, Vertiv saw a 42% increase in its adjusted operating profit to $249 million, compared to Q1 2024, as the company pointed towards continued acceleration in the data center market, including the deployment of high-performance compute, and increased velocity in its opportunity pipeline to orders.
“We are seeing order patterns with longer lead times based on customer build schedules, largely in 2025 and beyond, suggesting AI is starting to scale,” said Giordano Albertazzi, CEO of Vertiv. “We are continuing to advance our portfolio to enable high-density and GPU based deployments. With our global capacity, the most complete portfolio of critical digital infrastructure solutions across the entire thermal and power technology spectrum, vast global service network and alignment with key technology partners, Vertiv is uniquely positioned and ready to bring scale and support development of the entire AI ecosystem.”
Digital infrastructure company Equinix, Inc. (NASDAQ: EQIX) recently announced a joint venture with PGIM Real Estate for a $600 million project to develop and operate the first xScale data center in the US, located in California’s Silicon Valley. Together, Equinix and PGIM had already successfully opened the first xScale data center in Australia in 2022, after a similar US$575 million JV was announced in 2021.
Under the terms of the agreement, PGIM Real Estate will control an 80% equity interest in the JV, while Equinix will own the remaining 20% equity interest. Equinix xScale data centers allow hyperscale companies to expand their core deployments within Equinix IBX data centers. This setup supports growth across more than 70 global metros on a unified platform that facilitates direct interconnections with over 10,000 customers.
The new joint venture, alongside Equinix’s existing hyperscale collaborations in Europe, Asia-Pacific, and the Americas, will enhance the global xScale data center portfolio. Once fully constructed, this expansion will exceed $8 billion across more than 35 facilities, providing over 725 megawatts of power capacity.
Building upon the confidence of one of its existing “Magnificent Seven” Big Tech customers, Innodata Inc. (NASDAQ: INOD) recently announced it has been awarded three new large language model (LLM) development programs, totaling approximately $20 million of additional annualized run rate revenue. Before these new awards, the annualized run rate revenue from the customer was about $23 million. Innodata anticipates signing an amendment to its agreement with this customer that will reflect these awards within the next few weeks. Work on the newly awarded programs has already started by Innodata.
“We are very excited to announce this significant expansion,” saidJack Abuhoff, CEO of Innodata. “Moreover, we anticipate potential opportunities for further expansion in 2024. The customer continues to express how our high-quality, large-scale, custom data results in superior fine-tuning of their LLMs and that their AI engineering teams greatly value the Innodata partnership.”
Innodata provides large technology companies with scaled data services for refining LLMs and offers LLM evaluation services. By the end of 2023, Innodata had secured five of the top seven major tech firms as clients for its LLM services.
With its own array of big tech allies, Salesforce, Inc. (NYSE: CRM) recently unveiled its Zero Copy Partner Network, a global ecosystem of technology and solution providers building secure, bidirectional zero copy integrations with Salesforce Data Cloud which integrates both structured and unstructured customer data into a comprehensive 360-degree view accessible within Salesforce itself. This integration enables teams to make informed decisions directly within their workflow.
“In today’s digital landscape, companies struggle with islands of data spread across various systems,” said Brian Millham, President and Chief Operating Officer at Salesforce. “With this global ecosystem of partners, companies can access all of their data, no matter where it resides, and unlock the power of all of that data within Salesforce — creating more personalized customer interactions and establishing a foundation for trusted AI, in less time and at lower cost.”
The network will feature a list of initial partners that will include such big names as Amazon Web Services (AWS), Databricks, Google Cloud, and Snowflake, while also adding Microsoft. Together, the network partners are all committed to zero copy integrations with Salesforce that give customers a secure and cost-effective way to connect and take action on all of their data.
Source: https://usanewsgroup.com/2023/10/26/unlocking-the-trillion-dollar-ai-market-what-investors-need-to-know/ 
CONTACT:USA NEWS [email protected](604) 265-2873
DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. USA News Group is a wholly-owned subsidiary of Market IQ Media Group, Inc. (“MIQ”). MIQ has been paid a fee for Avant Technologies Inc. advertising and digital media from the company directly. There may be 3rd parties who may have shares Avant Technologies Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ own shares of Avant Technologies Inc. which were purchased as a part of a private placement. MIQ reserves the right to buy and sell, and will buy and sell shares of Avant Technologies Inc. at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material disseminated by MIQ has been approved by the above mentioned company; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market, or through further private placements and/or investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

View original content:https://www.prnewswire.co.uk/news-releases/exploring-the-surge-in-digital-infrastructure-spending-driven-by-generative-ai-innovations-302138670.html

Continue Reading

Artificial Intelligence

nodeQ Launches PQtunnel™: The Leading-Edge Cybersecurity Solution for Quantum-Safe Communication

Published

on

nodeq-launches-pqtunnel™:-the-leading-edge-cybersecurity-solution-for-quantum-safe-communication

The latest application developed by nodeQ simplifies the migration to Post-Quantum Cryptography for both SMEs and large enterprises
YORK, England, May 7, 2024 /PRNewswire/ — The advent of Quantum Computing poses a significant threat to existing public-key cryptosystems. A large quantum computer can break algorithms like RSA or ECDH, which form the backbone of current internet security. Already today, confidential data is in danger: It can be harvested now to be decrypted later when a quantum computer can run Shor’s factorization quantum algorithm on a sufficiently large number of qubits.

This vulnerability exposes a large number of applications to potential security breaches, threatening our trillion-dollar digital economy. Multiple sectors are under threat: Financial Institutions, government entities, telecommunications companies, cloud providers, the healthcare industry, the defense sector, universities and research centers, and virtually any IT-based enterprise that relies on encrypted data.
Companies must transition IT infrastructures to quantum-resistant solutions, such as Post-Quantum Cryptography (PQC). In the US the transition to PQC is set to start in 2024, as a result of Biden’s 2022 Computing Cybersecurity Preparedness Act and the end of NIST standardization.
nodeQ has developed PQtunnel™, a groundbreaking tool designed to assist businesses – ranging from SMEs to large enterprises – in transitioning their end-to-end (E2E) secure communication to PQC. This innovative software application is available in two variants: PQtunnel™ TLS and PQtunnel™ SSH, meeting diverse business requirements.
PQtunnel™ TLS is an enterprise-oriented tunneling application that leverages the Transport Layer Security (TLS) protocol to secure traffic between a client (or a proxy) and the target application. This solution has been thoroughly tested on various enterprise-grade applications, such as GitLab EE, demonstrating its effectiveness and reliability.
On the other hand, PQtunnel™ SSH offers a comprehensive Quantum-Safe SSH server, alongside a client equipped with a user-friendly interface. This software suite is designed for secure shell operations, ensuring the highest level of security and ease of use.
Both PQtunnel™ variants utilize a wide range of PQC algorithms, including the most recent ones under standardization by NIST, and hybrid algorithms. This approach combines the stability of current cryptographic methods with the quantum-safeness of new cryptographic suites, offering unmatched security against emerging cyber threats.
Developed as cloud-native applications, both variants of PQtunnel™ are designed to facilitate easy distribution and provide flexibility in a wide range of scenarios. Secure Post-Quantum tunneling to your GitLab server, quantum-safe data transfer, secure cloud IT management, and PQC benchmarking are just a few of the use cases where PQtunnel™ can be applied, showcasing its versatility and significance for today’s cybersecurity landscape.
Ignazio Pedone, the cybersecurity lead at nodeQ, emphasized the significance of their latest security product, stating, “This security product represents an important step towards a more effective and robust application of quantum-safe cryptography for enterprises.”
Various early customers have already adopted PQtunnel™ to test their readiness to migrate to quantum-safe cryptography. PQC is going to play an important role for telecom operators.
“At Fibraweb, PQtunnel demonstrated our readiness for quantum-security migration,” says Walid Bounassif, CEO of Fibraweb (an Italian telco). “The software created quantum-resistant connections between external clients and our internal servers, showing that post-quantum encrypted communication can efficiently be implemented for remote IT administration and secure file transfer.”
PQC is essential for medium to large enterprises, including educational institutions like universities, where maintaining data confidentiality at various levels is crucial. At the University of York (UK), PQtunnel™ has been deployed for the quantum-safe transfer of documents. This pioneering demonstration, the first of its kind in the world within the education sector, actively involved staff and students from the Department of Computer Science.
“PQtunnel has effectively established high-speed, quantum-resistant connections both within and beyond the campus perimeter,” says Prof Paul Cairns (Head of the Computer Science Department at the University of York, UK). “This technology has clearly demonstrated its capacity for facilitating quantum-secure data transfers, affirming its readiness to enhance our university’s digital infrastructure.”
For additional information about PQtunnel™, nodeQ, and their range of products, the reader can visit their website at www.nodequantum.com.
 Key Features

Crypto-Agility: implements all NIST PQC algorithms to counteract the quantum threat.
Cross-Platform: available for the most adopted operating systems and hardware architectures.
Easy Setup: no need for long or complex installation procedures to get started.
On-the-Fly Benchmarking and Optimization: can benchmark and optimize high-level security protocols against all the available combinations of PQC algorithms for key exchange and digital signature.

Target Customers

Financial Institutions
Telecommunications Companies
Universities and Research Centers
Cloud Providers
Healthcare Industry
Government Entities
Defense Sector
Manufacturing Companies
SMEs handling confidential data

About nodeQ
At nodeQ, we are pioneering the future of computer networks, leveraging our deep expertise in quantum communication, artificial intelligence, and software-defined networking. Our primary objective is to transition computer networks to quantum security, placing a critical emphasis on maintaining speed, performance, and usability at the heart of this transformation.
Contacts
Stefano Pirandola
[email protected]
Request a demo or a brochure at [email protected] or visit www.nodequantum.com.
Photo – https://mma.prnewswire.com/media/2406722/PQtunnel_Graphics.jpg
View original content:https://www.prnewswire.co.uk/news-releases/nodeq-launches-pqtunneltm-the-leading-edge-cybersecurity-solution-for-quantum-safe-communication-302138586.html

Continue Reading
Advertisement
Advertisement

Latest News

Trending